MedPath

Electromagnetic Interference and Automobile Remote Keyless Entry in Cardiovascular Implantable Electronic Device (CIED) Patients

Conditions
Electromagnetic Interference in Cardiovascular Implantable Electronic Device
Registration Number
NCT03016390
Lead Sponsor
Chiang Mai University
Brief Summary

Cardiovascular Implantable Electronic device (CIED) is a evolution therapy and number of patients with it are growing rapidly. Electromagnetic interference causing device malfunction is not uncommon, Radiofrequency Identification system is among its plausible source. Patients with CIEDs are at risk of exposure to this novel product in their daily living especially automobile keyless access system. Only informal studies have been conducted and not be published. Formal and systemic evaluation and tests are crucial.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Age more than 18 years old
  2. Able to give informed consent
  3. Implanted with functioning pacemakers or AICD more than 3 months
  4. Adequate and stable all device parameters
  5. Able to operate self triggering event recorders (at least 30 seconds)
Exclusion Criteria
  1. Patient with single chamber (Atrial) pacemaker (AAI or AAIR)
  2. Presence of unstable hemodynamic or conditions
  3. Presence of sustained or ongoing arrhythmia, besides atrial fibrillation/atrial flutter in single (ventricle) chamber device or Atrio-ventricular block
  4. Documented of over-sensing episodes under regular sensitivity threshold (0.25 mV or more in the atrial channel and 0.75 mV or more in the ventricular channel, for permanent pacemaker device, and manufacture default setting in Automatic Implantable Cardioverter-Defibrillator, AICD)
  5. Lack of noise oversensing detection/trigger and Electrogram (EGM) storage capability
  6. Lack of tachyarrhythmia detection and episode storage capability

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of any Electromagnetic interferenceImmediately after completion of the protocol test
Secondary Outcome Measures
NameTimeMethod
Incidence of pacing inhibition in ventricular channelImmediately after completion of the protocol test
Incidence of noise reversionImmediately after completion of the protocol test
Incidence of ventricular tachycardia/fibrillation detectionImmediately after completion of the protocol test
© Copyright 2025. All Rights Reserved by MedPath